Bariatric Surgical Techniques: How to Choose?

Authors

  • Eduardo Lima da Costa Centro de Responsabilidade Integrado de Obesidade – ULS São João, Porto, Portugal; Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Centro de Tratamento de Obesidade do Hospital Lusíadas, Porto, Portugal https://orcid.org/0009-0003-0813-3801

DOI:

https://doi.org/10.34635/rpc.1141

Keywords:

Bariatric Surgery, Obesity/drug therapy, Obesity/surgery

Abstract

Bariatric and metabolic surgery remains the most effective and durable treatment for severe obesity and its multiple metabolic and mechanical comorbidities. However, the growing range of effective procedures raises a central question: how to select the most appropriate technique for each patient? This review critically examines recent literature (2021-2025), including the updated ASMBS/IFSO guidelines, intending to summarize the principles, outcomes, and indications of the main bariatric procedures. Sleeve gastrectomy (SG) has consolidated its position as the most widely performed procedure worldwide due to its simplicity and safety. Roux-en-Y gastric bypass (RYGB) remains the reference technique in patients with long-standing type 2 diabetes or gastroesophageal reflux disease (GERD), despite a higher risk of nutritional deficiencies. Procedures with greater metabolic potency—one-anastomosis gastric bypass (OAGB), biliopancreatic diversion/duodenal switch (BPD/DS), and single-anastomosis duodenal bypass with sleeve gastrectomy (SADI-S)—achieve superior weight and metabolic outcomes, though they require stringent nutritional surveillance. Emerging operations such as intestinal bipartition and novel endoscopic interventions expand the therapeutic spectrum but should be performed only in specialized, high-volume centers and within structured clinical protocols. Surgical choice must be individualized, integrating clinical-metabolic phenotype (BMI, GERD, diabetes, steatohepatitis, age), operative risk, patient preference, and the expertise of the multidisciplinary team. Success should be measured beyond weight loss, encompassing remission of comorbidities, preservation of lean mass, and improved quality of life. There is no universally ideal operation. The decision should rely on clinical, metabolic, and functional criteria, supported by experienced teams and robust quality programs. The future of bariatric surgery will be driven by the integration of surgical, pharmacological, and endoscopic strategies within a framework of personalized metabolic medicine—potentially enhanced by artificial intelligence-based algorithms.

Downloads

Download data is not yet available.

References

Faria G, Preto J, Lima da Costa E, Guimarães JT, Calhau C, Taveira-Gomes A. Acute improvement in insulin resistance after laparoscopic Roux-en-Y gastric bypass: is 3 days enough to correct insulin metabolism? Obes Surg. 2013;23:103-10. doi:10.1007/s11695-012-0803-0.

Cleveland E, Tchang BG, Kaplan LM. Artificial intelligence and precision medicine in obesity and metabolic surgery. Nat Rev Endocrinol. 2024;20:23-35.

De Luca M, Angrisani L, Himpens J, Ramos A, Shikora S, Kinsman R, et al. IFSO Worldwide Survey 2021: global bariatric surgery data on volume, safety and procedure distribution. Obes Surg. 2022;32:2693-707. doi:10.1007/s11695-022-06004-6.

Arterburn DE, Courcouas AP, et al. Weight outcomes after bariatric surgery at 10 years in the PCORNet Bariatric Study. JAMA. 2020;324:879-87. doi:10.1001/jama.2020.12567.

Peterli R, Wolnerhanssen BK, Peters T, Vetter D, Kroll D, Borbely Y, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and quality of life at 5 years (SM-BOSS trial). JAMA. 2018;319:255-65. doi:10.1001/jama.2017.20897.

Oor JE, Roks DJ, Unlu C, Hazebroek EJ. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Ann Surg. 2016;263:249-55. doi:10.1097/SLA.0000000000001331.

Clapp B, Harper B, Dodoo C, Barrientos A, Cutshall M, Ponce J. Trends in weight regain following Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2018;28:2413-21. doi:10.1007/s11695-018-3235-2.

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-85. doi:10.1056/NEJMoa1200111.

Sjostrom L. Review of the evidence: bariatric surgery reduces long-term mortality and morbidity. Int J Obes. 2013;37:281-92. doi:10.1038/ijo.2012.160.

Courcouas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, et al. Long-term outcomes of bariatric surgery: weight loss and health changes through 7 years in the LABS study. JAMA Surg. 2015;150:931-40. doi:10.1001/jamasurg.2015.1534.

Robert M, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khammhommala L, et al. Efficacy and safety of one-anastomosis gastric bypass versus Roux-en-Y gastric bypass: a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393:1299-309. doi:10.1016/S0140-6736(19)30475-1.

Ruiz-Tovar J, Carbajo MA, Jiménez JM, Castro MJ, Ferrer R, Morales V, et al. One-anastomosis gastric bypass versus Roux-en-Y gastric bypass: 10-year results of a prospective cohort study. Obes Surg. 2023;33:96-106. doi:10.1007/s11695-022-06313-9.

Sánchez-Pernuate A, Rubio-Herrera MA, Pérez-Aguirre ME, García-Caballero M, Pérez-Aguirre E, Torres A. Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S): long-term results and metabolic outcomes. Obes Surg. 2022;32:743-52. doi:10.1007/s11695-021-05767-0.

Topart P, Becouarn G, Ritz P. Weight loss and nutritional outcomes 10 years after biliopancreatic diversion with duodenal switch. Obes Surg. 2020;30:687-94. doi:10.1007/s11695-019-04235-9.

Santoro S, Malzoni CE, Velhote MCP, Milleo FQ, Klajner S, Castro LC, et al. Digestive adaptation with intestinal bipartition: a physiologic operation for metabolic surgery. Obes Surg. 2006;16:1371-9. doi:10.1381/096089206778870086.

Sánchez-Pernuate A, Rubio-Herrera MA, Pérez-Aguirre ME, Torres A. Single-anastomosis sleeve ileal (SASI) bypass: one to three-year results in a prospective study. Obes Surg. 2021;31:2552-60. doi:10.1007/s11695-021-05382-z.

Oliveira CR, Santos-Sousa H, Costa MP, Amorim-Cruz F, Bouca-Machado R, Nogueiro J, et al. Efficiency and safety of single-anastomosis sleeve ileal (SASI) bypass in the treatment of obesity and associated comorbidities: a systematic review and meta-analysis. Langenbecks Arch Surg. 2024;409:221. doi:10.1007/s00423-024-03413-w.

Abu Dayyeh BK, Bazerbachi F, Vargas EJ, Acosta A, Lopez-Nava G, Galvao Neto M, et al. Endoscopic sleeve gastroplasty for obesity: 5-year outcomes from a multicenter study. Gastroenterology. 2023;165:454-65. doi:10.1053/j.gastro.2023.05.007.

van Baar AC, Meiring S, Janssen IMC, Dallinga-Thie GM, Van der Woude CJ, Van Baarlen J, et al. Duodenal mucosal resurfacing combined with GLP-1 receptor agonists for type 2 diabetes: metabolic outcomes and safety. (Incomplete reference in text.)

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Poires W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37. doi:10.1001/jama.292.14.1724.

Angrisani L, De Luca M, Himpens J, Ramos A, Shikora S, Kow L. Bariatric surgery worldwide 2023: the IFSO Global Registry Report. Obes Surg. 2024;34:456-72. doi:10.1007/s11695-023-06891-3.

DeMaria EJ, Ponce J, Nguyen NT, Hutter M, Morton JM, Kothari SN, et al. ASMBS Bariatric Surgery Registry 2023: safety, outcomes, and national trends. Surg Obes Relat Dis. 2023;19:397-412. doi:10.1016/j.sord.2023.02.004.

Dawes AJ, Maggard-Gibbons M, Maher AR, Booth MJ, Miake-Lye I, Beroes JM, et al. Mental health conditions among patients undergoing bariatric surgery: systematic review and meta-analysis. JAMA. 2016;315:150-63. doi:10.1001/jama.2015.18118.

Eisenberg D, Shikora S, Kim JJ, Jensen MD, Still CD, le Roux CW, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18:1345-56. doi:10.1016/j.sord.2022.09.010.

Rubino F, Cohen RV, Mingrone G, Arterburn DE, Schauer PR, DeMaria EJ, et al. Bariatric and metabolic surgery in clinical practice: 2023 international consensus update. Nat Rev Endocrinol. 2023;19:577-96. doi:10.1038/s41574-023-00860-8.

Sarwer DB, Heinberg LJ. A review of the psychosocial and behavioral aspects of bariatric surgery. Obes Surg. 2020;30:2935-46. doi:10.1007/s11695-020-04675-w.

Lee Y, Doumouras AG, Yu J, Anvari M, Gmore S. Procedure selection and long-term outcomes in bariatric surgery: a personalized approach. Lancet Diabetes Endocrinol. 2024;12:103-17. doi:10.1016/S2213-8587(23)00315-6.

Arman GA. Outcomes of revision bariatric surgery: ASMBS/IFSO 2022 position statement. Surg Obes Relat Dis. 2023;19:1151-65.

Nedelcu M. Sleeve to bypass and sleeve to SADI-S conversions: indications and outcomes. Obes Surg. 2023;33:1442-53.

Ramos AC, et al. Revision metabolic surgery: global trends and safety outcomes. World J Surg. 2024;48:511-22.

Clapp B. Revisional bariatric surgery: analysis of the MBSAQIP database 2020-2023. Surg Obes Relat Dis. 2024;20:12-22.

Deitel M. Reversal and reoperation after bariatric procedures: a systematic review and meta-analysis. Obes Surg. 2023;33:2867-82.

IFSO/ASMBS Guidelines Committee. Indications for revision metabolic and bariatric surgery-2024 update. Surg Obes Relat Dis. 2025;21:245-57.

Brown WA, Liem R, Al-Sabah S, Anvari M, Boza C, Cohen RV, et al.; IFSO Global Registry Collaboration. Metabolic bariatric surgery across the IFSO chapters: key insights on baseline patient demographics, procedure types, and mortality from the eighth IFSO Global Registry Report. Obes Surg. 2024;34:1764-77. doi:10.1007/s11695-024-07196-3.

Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002. doi:10.1056/NEJMoa2032183.

Rubino D, Cohen RV, Mingrone G. Role of incretin-based pharmacotherapy before and after metabolic surgery. Nat Rev Endocrinol. 2024;20:241-56.

Perdomo CM, Cohen RV, Schauer PR. Defining success in metabolic surgery: beyond weight loss. Obes Surg. 2022;32:3895-904. doi:10.1007/s11695-022-06399-3.

Hsu S, Farrell TM. Comprehensive outcomes and definitions of success in bariatric surgery. Surg Obes Relat Dis. 2023;19:1153-62. doi:10.1016/j.sord.2023.05.014.

Bellicha A, van Baak MA, Battista F, Beaulieu K, Blundell JE, Busetto L, et al. Effect of exercise training before and after bariatric surgery: A systematic review and meta-analysis. Obes Rev. 2021;22:e13296. doi:10.1111/obr.13296.

O'Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes of bariatric surgery: weight loss and health changes through 10 years in the LABS and PCORNet studies. JAMA Surg. 2024;159:411-22. doi:10.1001/jamasurg.2024.0678.

Dawes AJ, Maggard-Gibbons M, Maher AR, Booth MJ, Miake-Lye I, Beroes JM, et al. Mental health conditions among patients undergoing bariatric surgery: systematic review and meta-analysis. JAMA. 2016;315:150-63. doi:10.1001/jama.2015.18118.

Angrisani L, De Luca M, Himpens J, Ramos A, Shikora S, Kow L. Bariatric surgery worldwide 2023: the IFSO Global Registry Report. Obes Surg. 2024;34:456-72.

Rubino F, Cohen RV, Mingrone G, Arterburn DE, Schauer PR, DeMaria EJ, et al. Bariatric and metabolic surgery in clinical practice: 2023 international consensus update. Nat Rev Endocrinol. 2023;19:577-96.

Published

2026-02-08

Most read articles by the same author(s)